RT Journal Article
SR Electronic
T1 Concurrent 3D super resolution on intensity and segmentation maps improves detection of structural effects in neurodegenerative disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.02.02.23285376
DO 10.1101/2023.02.02.23285376
A1 avants, brian
A1 Tustison, Nicholas J
A1 McMillan, Corey T
A1 Gosselin, Taylor
A1 Gunn, Roger
A1 Hesterman, Jacob
YR 2023
UL http://medrxiv.org/content/early/2023/02/06/2023.02.02.23285376.abstract
AB We propose a new perceptual super resolution (PSR) method for 3D neuroimaging and evaluate its performance in detecting brain changes due to neurodegenerative disease. The method, concurrent super resolution and segmentation (CSRS), is trained on volumetric brain data to consistently upsample both an image intensity channel and associated segmentation labels. The simultaneous nature of the method improves not only the resolution of the images but also the resolution of associated segmentations thereby making the approach directly applicable to existing labeled datasets. One challenge to real world evaluation of SR methods such as CSRS is the lack of high resolution ground truth in the target application data: clinical neuroimages. We therefore evaluate CSRS effectiveness in an adjacent, clinically relevant signal detection problem: quantifying cross-sectional and longitudinal change across a set of phenotypically heterogeneous but related disorders that exhibit known and differentiable patterns of brain atrophy. We contrast several 3D PSR loss functions in this paradigm and show that CSRS consistently increases the ability to detect regional atrophy both longitudinally and cross-sectionally in each of five related diseases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study used (or will use) ONLY openly available human data that were originally located at: https://ida.loni.usc.edu/ (in particular 4RTNI, NIFD), PPMI https://www.ppmi-info.org and http://www.humanconnectomeproject.org/data/ Further details are in the manuscript.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors https://ida.loni.usc.edu/ http://www.humanconnectomeproject.org/data/